Unmatched Expertise.
Trusted Partnerships.
Healthcare Dedicated.

Providing aligned strategic and financial advisory services to healthcare companies of all sizes, from global corporations to venture backed businesses. Differentiated, attentive and independent advice in the context of long-term relationships.
View Transactions

Featured Transactions

Mergers, Acquisitions & Strategic Advisory

MTS served as exclusive financial advisor to CleanSlate on its sale to Spero Health

Mergers, Acquisitions & Strategic Advisory

Zymeworks Inc. enters into a definitive agreement to acquire Theravance Biopharma, Inc. for $929mm

Mergers, Acquisitions & Strategic Advisory

MTS served as exclusive financial advisor to Knox Lane on its acquisition of Cross Country Healthcare (Nasdaq:CCRN)

Mergers, Acquisitions & Strategic Advisory

MTS served as lead financial advisor to Golden State Medical Supply, a portfolio company of Court Square, on its sale to Revelar Capital

Mergers, Acquisitions & Strategic Advisory

MTS served as financial advisor to Galapagos’ Independent Board of Directors on its collaboration agreement with Gilead Sciences for Ouro Medicines’ assets

Mergers, Acquisitions & Strategic Advisory

MTS served as exclusive financial advisor to CirrusMD on its sale to Quantum Health

Mergers, Acquisitions & Strategic Advisory

MTS served as exclusive financial advisor to Alma on its sale to Spring Health

Mergers, Acquisitions & Strategic Advisory

MTS served as exclusive financial advisor to DispatchHealth in the sale of its Mobile Imaging business to TridentCare

Mergers, Acquisitions & Strategic Advisory

MTS served as exclusive financial advisor to Neurocrine Biosciences, on its divestment of its European commercial business (Neurocrine Group Limited) to Immedica Pharma

Mergers, Acquisitions & Strategic Advisory

MTS served as exclusive financial advisor to Englewood Health on its merger with RWJBarnabas Health

Mergers, Acquisitions & Strategic Advisory

MTS served as exclusive financial advisor to Opsidio on its sale of sole asset, OpSCF, to Insmed (NASDAQ: INSM)

Mergers, Acquisitions & Strategic Advisory

MTS served as exclusive financial advisor to Tempest Therapeutics on its acquisition of 4 clinical and preclinical CAR-T assets from Factor Bioscience

Who we are

Trusted Healthcare Advisory Built on Deep Sector Knowledge

We drive business transformations throughout the healthcare landscape. MTS blends the agility of a boutique investment bank with the scale and experience of a global advisory firm.
See What Sets Us Apart
$133
Billion
Advised Transactions
25+
Years
Of Healthcare Experience
20
Years
Average Partner Experience
306
Transactions
Completed
Defining excellence in healthcare advisory

Strategic Guidance Across the
Full Healthcare Spectrum

A Team of Long-Term Strategists

Building Enduring Value Through Lasting Client Partnerships

Meet Our Team